As the coronavirus outbreak recedes in many parts of the U.S., the Pacific Northwest has emerged as an outlier gripped by a late spring surge that has filled hospitals in the metro areas around Seattle and Portland.
In recent weeks, the governors of both states have hit the brakes on reopening plans in hopes of countering the rapid spread of the more contagious B.1.1.7. variant of the coronavirus, first identified in the U.K.
In Washington state, new hospital admissions for COVID-19 have been higher during this current surge than at any other time, except for this past winter.
4th Wave Of COVID-19 Hospitalizations Hits Washington State
Update RequiredTo play audio, update browser or Flash plugin.
Sydney Porter of Bellevue, Wash., receives her COVID-19 vaccination from Kristine Gill, with the Seattle Fire Department s Mobile Vaccination Teams, before the game between the Seattle Mariners and the Baltimore Orioles at T-Mobile Park on May 5 in Seattle. A late spring COVID-19 surge has filled hospitals in the metro areas around Seattle.
Steph Chambers / Getty Images
As the coronavirus outbreak recedes in many parts of the U.S., the Pacific Northwest has emerged as an outlier gripped by a late spring surge that has filled hospitals in the metro areas around Seattle and Portland.
IMV Appoints Dr Michael Kalos to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
4th Wave Of COVID-19 Hospitalizations Hits Washington State
at 8:44 am NPR
As the coronavirus outbreak recedes in many parts of the U.S., the Pacific Northwest has emerged as an outlier â gripped by a late spring surge that has filled hospitals in the metro areas around Seattle and Portland.
In recent weeks, the governors of both states have hit the brakes on reopening plans in hopes of countering the rapid spread of the more contagious B.1.1.7. variant of the coronavirus, first identified in the U.K.
In Washington state, new hospital admissions for COVID-19 have been higher during this current surge than at any other time, except for this past winter.
Precigen Reports First Quarter 2021 Financial Results
- Company on track to achieve stated 2021 milestones -
- Initiated Phase 2 clinical trial of PRGN-2009 AdenoVerse™ immunotherapy -
- Initiated Phase 1 clinical trial of PRGN-2012 AdenoVerse immunotherapy in patients with recurrent respiratory papillomatosis (RRP) -
- Upcoming presentation at FOCIS Virtual Annual Meeting to provide clinical progress for AG019 ActoBiotics™ in Type 1 diabetes (T1D) -
News provided by
Share this article
Share this article
GERMANTOWN, Md., May 10, 2021 /PRNewswire/ Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced first quarter 2021 financial results.